Brings over 35 years of oncology drug development experience, including senior executive leadership roles at AstraZeneca and Daiichi Sankyo Led the development and approval of multiple breakthrough medicines such as ENHERTU®, TAGRISSO®, and LYNPARZA® Strengthens Ona's transition to a...
Hence then, the article about ona therapeutics appoints oncology drug development veteran dr antoine yver as chair to accelerate adc programs to clinical inflection points was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Ona Therapeutics Appoints Oncology Drug Development Veteran Dr. Antoine Yver as Chair to Accelerate ADC Programs to Clinical Inflection Points )
Also on site :
- Military and civil drills in Lithuania as concerns over Russia increase
- SAG-AFTRA Launches Verticals Agreement for Microdramas
- Driver dies after car crashes and catches fire in Clarkson